Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
Yvonne de Jong(Leiden University Medical Center), Judith V.M.G. Bovée(Leiden University Medical Center)
Cited by 57
Related Papers
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
|British Journal of Cancer|2018|61
Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
|BMC Cancer|2012|43
Targeting survivin as a potential new treatment for chondrosarcoma of bone
|Oncogenesis|2016|34